Dhruv Bansal

Saint Luke's Hospital

Papers

1

Total Citations

9

H-Index

1

About

Dhruv Bansal is a clinician-researcher whose work sits at the intersection of precision oncology and minimally invasive surgical innovation. His most cited study, a 2023 case report, documents a remarkable therapeutic response to osimertinib in a colorectal cancer patient harboring an EGFR T790M mutation—a finding that challenges conventional tissue-specific treatment paradigms and highlights the potential of liquid biopsy-guided therapy. This work, with 9 citations, underscores his focus on translating molecular insights into actionable clinical strategies. Beyond targeted therapy, Bansal is a strong advocate for the expanding role of minimally invasive surgery in malignant disease management. He has contributed to the growing body of evidence supporting laparoscopic, thoracoscopic, and robotic approaches for complex procedures like oesophagectomy, emphasizing their advantages in visualization and recovery despite a steep learning curve. His research bridges the gap between advanced surgical technique and genomic medicine, offering a dual perspective that is increasingly vital in modern oncology. Bansal’s work is particularly impactful for trainees and researchers interested in how surgical and medical oncology can converge to improve patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Response to osimertinib in a colorectal cancer patient with an <i>EGFR</i> T790M mutation: A case report
9 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Saint Luke's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago